Your browser doesn't support javascript.
loading
Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection.
Choteau, Mathilde; Scohy, Anaïs; Messe, Stéphane; Luyckx, Mathieu; Dechamps, Mélanie; Montiel, Virginie; Yombi, Jean Cyr; Gruson, Damien; Limaye, Nisha; Michiels, Thomas; Dumoutier, Laure.
Afiliação
  • Choteau M; Experimental Medicine Unit, de Duve Institute, Université Catholique de Louvain, 74 Avenue Hippocrate, 1200, Brussels, Belgium.
  • Scohy A; Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Messe S; Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.
  • Luyckx M; Virology Unit, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Dechamps M; Department of Gynecology-Andrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Montiel V; Tumor Infiltrating Lymphocytes Unit, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Yombi JC; Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Gruson D; Cardiovascular Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Limaye N; Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Michiels T; Pôle de Recherche Pharmacologie et de Thérapeutique (FATH), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Dumoutier L; Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.
Sci Rep ; 12(1): 2077, 2022 02 08.
Article em En | MEDLINE | ID: mdl-35136139

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Imunidade Humoral / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Imunidade Humoral / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica